SCHEMBL19035795

SCHEMBL19035795

CC/C=C(\C)OCCN1CCOCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.42
ALDH1A1 P00352 8/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 1/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
HTR2A P28223 1/20 0.40
MAPK1 P28482 1/20 0.40
SCN1A P35498 1/20 0.40
HTR2B P41595 1/20 0.40
KCNH2 Q12809 1/20 0.40
SCN2A Q99250 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
SCN3A Q9NY46 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19035791 0.84 PSMB1 (0.47) KMT2AMEN1SMN1; SMN2KDM4E
SCHEMBL19035793 0.83 PSMB1 (0.49) KMT2AMEN1SMN1; SMN2KDM4EHPGD
SCHEMBL19035796 0.83 HRH3 (0.40) ALDH1A1KMT2AMEN1HRH3KDM4E
SCHEMBL21303221 0.82 GAA (0.42) ATMALDH1A1L3MBTL1KMT2ALMNA
SCHEMBL65772 0.75 ATM (0.54) ATMALDH1A1L3MBTL1KMT2ALMNA
SCHEMBL15830173 0.75 ATM (0.46) ATMALDH1A1L3MBTL1KMT2ALMNA
SCHEMBL19035792 0.75 ALDH1A1 (0.41) ALDH1A1L3MBTL1KMT2AMEN1KCNH2
SCHEMBL4184236 0.72 ALDH1A1 (0.56) ATMALDH1A1L3MBTL1KMT2ALMNA
SCHEMBL13666861 0.72 ATM (0.48) ATMALDH1A1L3MBTL1KMT2ALMNA
SCHEMBL7045906 0.72 ALDH1A1 (0.44) ALDH1A1LMNAGAASMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9687548-B2 Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-06-27 US disclosed